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Background: Multiple sclerosis (MS) is a multi-focal progressive disorder of the central nervous system often resulting
in diverse clinical manifestations. Symptomatic fatigue is quite common in people with MS (PwMS), with prevalence as
high as 85%. Nevertheless, it remains poorly understood and its association with walking capabilities unclear. Therefore,
the objective of this investigation was to examine the relationship between symptomatic fatigue and spatio-temporal
parameters of gait in PwMS based on an instrumented treadmill.
Methods: One hundred and twenty-four relapsing-remitting patients diagnosed with MS, 84 women and 40 men
aged 42.6 (S.D = 11.9), participated in this investigation. A convenience sample of 25 apparently healthy subjects,
15 women and 10 men aged 40.3 (S.D = 11.1), served as controls. Gait spatiotemporal parameters were obtained
using the Zebris FDM-T Treadmill (Zebris1 Medical GmbH, Germany). The Modified Fatigue Impact Scale (MFIS), a
self-reported questionnaire, was used to determine the level of symptomatic fatigue in the MS study group.
PwMS were divided into two groups: fatigued and non-fatigued.
Results: Forty-four PwMS were classified as suffering from fatigue (mean MFIS = 52.0, S.D = 13.7); 80 were classified as
non-fatigued (mean MFIS = 14.5, S.D = 14.5). Individuals in the fatigued group walked slower than those in the
non-fatigued group; 1.7 (S.D = 2.4) vs. 2.4 (S.D = 1.0); P < 0.001, respectively. Moreover, fatigued patients took
smaller steps, had a shorter stride length, prolonged stance, double support phase and a shorter single support
phase compared to the non-fatigued group. In the total group, fatigue was significantly correlated with 10 (out of 14)
spatiotemporal parameters of gait, however, correlation scores <0.40 were considered as weak correlations. According
to step one of the linear logistic regression analysis, the temporal gait component was found to explain 5.1% of the
variance related to symptomatic fatigue, R2 = 0.051, χ2 (1) = 6.511, P = 0.011. Step two of the model added the gait
spatial component, thus increasing the explaining variance to 9.3%; R2 = 0.093, χ2 (2) = 12.12, P = 0.002. The asymmetry
gait parameter did not contribute to the equation.
Conclusions: Perceived fatigue is related to walking speed in PwMS, nevertheless its contribution to level of fatigue is
limited.
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Multiple sclerosis (MS) is a multi-focal progressive dis-
order of the central nervous system often resulting in di-
verse clinical manifestations. Symptomatic fatigue and
walking capabilities are major challenges to the medical
and rehabilitation management of persons with MS
(PwMS). Both of these issues are quite common, with
prevalence of fatigue as high as 85% [1] and impaired gait
up to 75% [2]. Collectively, they are the main contributors
to advanced disability and a poorer quality of life [3].
The etiology of symptomatic fatigue in PwMS is un-
clear, though likely multi-factorial. The most commonly
proposed primary mechanisms of fatigue in MS encom-
pass the immune system or damage to the central nervous
system [4,5]. There is evidence that, in some instances, le-
sions in the basal ganglia, hypothalamus and parietal lobes
may play an important role [6-9]. Diffuse demyelination
and axonal lesions associated with reduced nerve conduc-
tion velocity and a prolonged refractory period have also
been discussed as producing fatigue in MS [10,11]. Previ-
ous trials have reported a strong association between
symptomatic fatigue with increased muscle fatigability
[12] and impaired central muscle activation in PwMS [13].
Recently, symptomatic fatigue has been found to be asso-
ciated with cerebellar and brainstem involvement [14].
Based on the knowledge that walking is a complex task
requiring integration of many brain resources [15], we
determined that it was necessary to examine the rela-
tionship between perceived fatigue and gait in PwMS.
This was reinforced by researchers who found an associ-
ation between elevated fatigue, impaired balance and a
higher risk of falls in this population [16,17].
Various studies examining the association between
gait performance and perceived fatigue have presented
mixed and limited results. Huisinga et al. [18] found a
correlation between fatigue measured by the Fatigue
Severity Scale and deficits in ankle power generation at
late stance, in mild disability MS participants (average
EDSS = 2.6).In contrast, Noguiera et al. did not observe
any interaction between the fatigue and ankle motion
in 12 PwMS [19]. Sacco et al. [20] found a correlation
between temporal-spatial parameters of gait (speed, ca-
dence and stride length) collected by the GAITRite mat
and fatigue (measured by the Wurzburg Fatigue Inven-
tory for MS), revealing a significant negative correlation
between velocity (r = -0.54), cadence (r = -0.44) and
stride length (r = -0.5).
In cross-sectional studies, Motl et al. [21] and Sandroff
et al. [22] reported similar findings when examining a
relatively large group of PwMS assessed by the GAITRite
mat and level of fatigue via the Fatigue Severity Scale.
Nonetheless, Morris et al. [23] and Crenshaw et al. [24]
found no correlation between fatigue and walking speed,
step length and double support time even after inductionof additional fatigue [25]. Thus, it seems that the evidence
as to the association between gait and fatigue in PwMS, is
still controversial.
An in-depth investigation clarifying the relationship
between definite gait parameters to perceived fatigue
may be facilitated in several ways. Firstly, management
of fatigue- related symptoms may be improved. For the
past several years, walking rehabilitation programs have
been proposed as a legitimate treatment option aimed
at reducing the level of perceived fatigue in PwMS [26].
Recently, Garret et al. demonstrated a reduction in symp-
tomatic fatigue and an increase in walking speed following
a 10-week community-based exercise program in 121
PwMS [27]. Secondly, quantified gait parameters may
serve as markers denoting level of fatigue indicating a pos-
sibility that fatigued PwMS adopt a specific walking pat-
tern. Recognition of this walking strategy may help
clinicians identify fatigued MS patients. Finally, new infor-
mation examining the relationship between gait impair-
ments and fatigue may generate additional trials in order
to examine the possibility of common central neural net-
works and resources. Therefore, the specific objective of
this investigation was to examine the relationship between
symptomatic fatigue and spatio-temporal parameters of
gait, based on an instrumented treadmill in PwMS.
Methods
Study design and participants
This study was a cross sectional study and included a con-
trol group. One hundred and twenty-four relapsing-
remitting patients diagnosed with MS, 84 women and 40
men aged 42.6 (S.D = 11.9), were recruited from the
Multiple Sclerosis Center, Sheba Medical Center, Tel-
Hashomer, Israel and participated in this investigation.
Inclusion criteria for participants required: (1) a neur-
ologist-confirmed diagnosis of definite relapsing-remit-
ting MS according to the revised McDonald criteria
[28]; (2) <6 on the Expanded Disability Status Scale
(EDSS), equivalent to the ability to walk without an assist-
ive device (e.g. a cane or walker); and (3) relapse-free for
at least 30 days prior to testing. Exclusion criteria in-
cluded: (1) orthopedic disorders that could negatively
affect mobility; (2) no history of psychiatric problems that
could negatively affect communication with the tester
while walking on the treadmill; (3) pregnancy; (4) blurred
vision; (5) cardiovascular disorders; (6) respiratory disor-
ders; (7) or taking steroids or fampridine. A convenience
sample of 25 apparently healthy subjects, 15 women and
10 men aged 40.3 (S.D = 11.1), served as controls. None of
the healthy participants reported any medication intake or
relevant health impairments (e.g. orthopedic, neurological,
or internal diseases). The study was approved by the
Sheba Institutional Review Board. All participating sub-
jects signed an informed consent form.
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Gait spatiotemporal parameters were obtained using the
Zebris FDM-T Treadmill (Zebris1 Medical GmbH,
Germany) fitted with an electronic mat of 10,240 mini-
ature force sensors, each approximately 0.85 cm × 0.85
cm, embedded underneath the belt. The treadmill’s con-
tact surface measures 150 cm x 50 cm and its speed can
be adjusted from 0.2 and 22 km/h at intervals of 0.1 km/h.
When the subject stands/walks on the treadmill, the force
exerted by his feet (the so-called reactive-normal force in
directions x, y and z) is recorded by the sensors at a sam-
pling rate of 120 Hz. Due to the high density of the sen-
sors, the foot is mapped at a high resolution to facilitate
even subtle changes in force distribution. Timing can also
be monitored. Dedicated software integrates the force sig-
nals and provides 2-D/3-D graphic representation of
major spatiotemporal parameters during gait. Major
spatio-temporal data included the following values: vel-
ocity (km/h), cadence (steps/min), stance phase (% gait
cycle (%GC)), single and double support phases (%GC),
width between steps (mm), step/stride length (cm) and
step/stride time (s). Furthermore, step length differences
and step time differences were calculated for each gait
trial. These parameters were calculated as the absolute
value of the differences between the corresponding right
and left values.
In 2012, Faude et al. reported high levels of between-
and within-day reliability in healthy seniors for the ma-
jority of spatiotemporal gait parameters recorded by the
Zebris treadmill system during walking, with coefficients
of variation typically below 5% and 7%, respectively [29].
Symptomatic fatigue
The Modified Fatigue Impact Scale (MFIS), a self-reported
questionnaire, was used to determine the level of symp-
tomatic fatigue in the MS study group. The MFIS [14] is a
multidimensional 21-item questionnaire capturing in-
formation as to the effects of fatigue within physical (9-
items), psychosocial (2-items) and cognitive (10-items)
domains over a period of four-weeks. Participants rated
the 21 items on a 5-point Likert-type scale, ranging
from never (0) to always (4). The MFIS yields three
subscale scores and an overall score ranging from 0 to
84 (the higher scores indicate more fatigue). Previous
studies have demonstrated that a total score of 38 is the
cutoff for discriminating fatigued from non-fatigued in-
dividuals [30,31]. In addition to its multidimensional
features, other advantages of the MFIS include easy to
use, good reproducibility, and a strong correlation with
results of the Fatigue Severity Scale (r = 0.68) [31].
Experimental design
Upon acceptance to the study, participants were instructed
to fill out the MFIS form. Prior to the treadmill gaitmeasurement phase, all participants actively partici-
pated in an adaptation-familiarization trial in order to
establish each individual’s speed level. Starting at a
fixed speed of 0.5 km/h, belt speed was increased by
0.3km/h every 15 seconds, in a stepwise manner. When
the participant informed the tester as to the speed that
best characterized his/her normal walking pace, it was
designated as his/her comfort speed. Following this
adaptation phase that lasted approximately 2 minutes, a
30 second break was provided. Subsequently, each par-
ticipant was instructed to walk barefoot on the tread-
mill for one consecutive minute at their comfort speed.
The time period was selected in concurrence with a previ-
ous study demonstrating that gait data measured for one
minute by the Zebris treadmill are valid markers of neuro-
logical impairment in PwMS [32]. Gait assessment was
performed at the Center of Advanced Technologies in Re-
habilitation, Sheba Medical Center. Measurements were
calculated by an experienced physical therapist specialized
in neurological rehabilitation.
Statistical analysis
MS subjects were divided into two groups: fatigued and
non-fatigued. Allocation was determined according to
the MFIS scores. The cut-off point for distribution was
set at 38. Pw MS with scores ≥38 were assigned to the
fatigued group and those with <38 were assigned to the
non-fatigued group. The selected cut-off point was based
on Flachenecker et al’s [33] study that correlated the
MFIS with another fatigue inventory and its defined
scores for fatigued and non-fatigued. Group differences
in age and gender distribution were determined using an
independent sample-t and chi-square test, respectively.
All spatio-temporal parameters of gait data were nor-
mally distributed according to the Kolmogorov-Smirnov
test. Thus, differences in gait parameters between PwMS
subgroups and controls were determined using the
multivariate analysis of variance (MANOVA) test. The
Bonferroni test enabled paired multiple comparisons be-
tween groups. The magnitudes of group differences were
indexed by a 95% confidence interval (95% CI).
The association between symptomatic fatigue expressed
by the MFIS questionnaire and spatio-temporal gait pa-
rameters were measured by Spearman’s rank-order correl-
ation coefficient tests. Correlation coefficients which are ≤
0.35 are generally considered to represent low or weak
correlations, 0.36 to 0.67 modest or moderate correlations,
and 0.68 to 1.0 strong or high correlations with r coeffi-
cients ≥ 0.90 very high correlations [34].
The evaluation of potential predictors for fatigue status
(i.e., the dependent variable) was calculated by a step-
wise linear regression analysis. Spatio-temporal parame-
ters of gait of the overall MS sample were entered in to
the model as covariates. At each subsequent step, the
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specific thresholds of F and P values (for variable inclu-
sion, F ≥ 1 and P ≤ 0.05; for exclusion, F < 1 and P > 0.05).
Importantly, in order to eliminate redundancy between
correlated gait variables, a principal component analysis
(PCA) was executed prior to the regression model. This
procedure extracts variables that carry the most variance
thus limiting a type I error. The PCA includes the Kaiser-
Meyer-Olkin measure of sampling adequacy and Bartlett’s
test of sphericity. Extraction of variables was based on ei-
genvalues >1.0. Oblimn with Kaiser normalization used as
the rotation method.
All analyses were performed using IBM SPSS statis-
tics software (Version 21.0 for Windows, SPSS Inc. NY,
USA). All reported P-values were two-tailed. The level
of significance was set at P < 0.05.Results
Demographics
Forty-four PwMS (35.5%) were classified as suffering from
fatigue (mean MFIS = 52.0, S.D = 13.7); 80 (64.5%) were
classified as non-fatigued (mean MFIS = 14.5, S.D = 14.5).
PwMS in the fatigued group had an elevated EDSS score
compared to the non-fatigued group, 3.7 (S.D = 1.4) vs. 1.2
(S.D = 1.1); P < 0.001, respectively. As to gender, the fa-
tigued group consisted of 68.2% women while the non-
fatigued, 67.5% women. No differences were observed
between the PwMS subgroups in terms of age, height, body
mass and disease duration. The individuals’ characteristicsTable 1 Demographic, anthropometric, clinical characteristics
Variables Mean (S.D.)
Patients without
fatigue (n = 80)
Patie
fatig




Disease duration (years) 7.0 (8.4) 8.1 (7
Height (cm) 169.4 (9.6) 167.8
Body mass (kg) 69.0 (15.9) 67.8
MFIS (range 0-84) 14.5 (14.5) 52.0
EDSS 2.5 (1.6) 3.7 (1
Pyramidal 1.6 (1.2) 2.1 (1
Cerebellar 0.9 (1.0) 1.3 (1
Sensory 0.7 (0.9) 1.2 (1
Brainstem 0.5 (0.2) 0.4 (0
Visual 0.2 (0.1) 0.2 (0
Cerebral 0.2 (0.5) 0.0 (0




The mean gait velocity obtained from the instrumented
treadmill for the study sample, was within the range for
usual gait speed among PwMS [35]. Individuals in the
fatigued group walked slower than participants in the
non-fatigued group; 1.7 (S.D = 2.4) vs. 2.4 (S.D = 1.0)
(km/h), P < 0.001, respectively. Moreover, fatigued pa-
tients took smaller steps, had a shorter stride length,
prolonged stance, double support phase and a shorter
single support phase compared to the non-fatigued
group. Additionally, the fatigued group exhibited a larger
asymmetry between the right and left legs in 3 (out of 4)
parameters; step length, single support and stance phase
compared to the non-fatigued group. No differences be-
tween groups were observed in terms of step width and
step time asymmetry. Gait variables in the subgroups of
PwMS are provided in Table 2.
Healthy vs. non-fatigued MS patients
Step time of the non-fatigued patients was significantly
slower compared to the healthy participants, 2.4 (S.D =
1.0) vs. 3.5 (S.D = 0.7) (km/h), P < 0.001, respectively. Add-
itionally, differences were observed in gait parameters re-
lated to spatial measurements. Patients walked with a
smaller step and stride length and a wider base of support.





ue (n = 44)
Healthy subjects
(n = 25)




(7.2) 168.7 (8.5) 0.364









Table 2 Spatio-temporal gait parameters of study participants







Non fatigue - fatigue Fatigue - Healthy Non fatigue - Healthy
Velocity (km/h) 2.4 (1.0) 1.7 (1.0) 3.5 (0.7) 25.4 (<0.001) 0.7 (0.2, 1.1) P = 0.001* −1.8 (-2.4, -1.2) P < 0.001* −1.1 (-1.7, -0.6) P < 0.001*
Cadence (steps/min) 96.1 (17.2) 86.2 (21.4) 100.6 (11.7) 6.3 (0.002) 9.9 (1.7, 18.0) P = 0.012* −14.4 (-25.5, -3.3) P = 0.006* −4.5 (-14.8, 5.7) P = 0.855
Mean Step time (sec) 0.65 (0.14) 0.78 (0.40) 0.60 (0.07) 5.4 (0.005) −0.13 (-0.24, -0.02) P = 0.015* 0.18 (0.02, 0.33) P = 0.018* 0.05 (-0.10, 0.18) P = 1.00
Mean Step length (sec) 40.2 (14.5) 32.0 (14.9) 58.1 (8.5) 26.7 (<0.001) 8.1 (1.8, 14.4) P = 0.07* −26.1 (-34.7, -17.4) P < 0.001* −17.9 (-25.9, -1.0) P < 0.001*
Mean Stance (%GC) 68.0 (5.2) 71.9 (6.5) 64.3 (2.1) 16.5 (<0.001) −3.9 (-6.3, -1.5) P < 0.001* 7.6 (4.3, 10.9) P < 0.001* 3.7 (0.6, 6.7) P = 0.012*
Mean Single support (% GC) 32.0 (5.2) 28.1 (6.5) 35.7 (2.1) 16.4 (<0.001) 3.9 (1.5, 6.3) P < 0.001* −7.6 (-10.9, -4.3) P < 0.001* −3.7 (-6.7, -0.7) P = 0.011*
Total Double support (% GC) 36.1 (10.5) 43.9 (13.1) 28.6 (4.1) 16.5 (<0.001) −7.8 (-12.7, -3.0) P < 0.001* 15.2 (8.6, 21.9) P < 0.001* 7.4 (1.3, 13.5) P = 0.012*
Mean Step width (cm) 13.6 (4.5) 14.7 (3.7) 11.1 (3.1) 5.8 (0.004) −1.1 (-3.0, 0.7) P = 0.430 3.6 (1.0, 6.1) P = 0.002* 2.4 (0.1,4.8) P = 0.036*
Mean Stride time (sec) 1.30 (0.28) 1.56 (0.80) 1.21 (0.15) 5.4 (0.005) −0.26 (-0.48, -0.04) P = 0.015* 0.35 (0.05, 0.65) P = 0.018* 0.09 (-0.19, 0.37) P = 1.00
Mean Stride length (cm) 80.3 (29.0) 64.0 (29.8) 116.2 (17.0) 26.7 (<0.001) 16.3 (3.6, 28.7) P = 0.007* −52.1 (69.4, -34.9) P < 0.001* −35.9 (-51.8, -20.0) P < 0.001*
Step length asymmetry (cm) 2.7 (2.40) 3.6 (3.28) 1.8 (1.32) 3.8 (0.025) −0.9 (-2.0, 0.3) P = 0.237 1.8 (0.18, 3.4) P = 0.024* 0.93 (-0.5, 2.4) P = 0.387
Step time asymmetry (msec) 0.03 (0.05) 0.07 (0.07) 0.01 (0.01) 10.8 (<0.001) −0.03 (-0.06, -0.008) P = 0.004* 0.06 (0.027, 0.091) P < 0.001* 0.03 (-0.002, 0.057) P = 0.08
Single support asymmetry (GC%) 2.2 (2.1) 2.6 (2.6) 0.7 (0.7) 6.1 (0.003) −0.40 (-1.4, 0.6) P = 0.983 1.9 (0.5, 3.2) P = 0.003* 1.5 (0.3, 2.7) P = 0.012*
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onstrated a larger asymmetry between the right and left
legs in the context of single support and stance phase. In
contrast, there were no differences in step length and time
associated with asymmetry. Gait variables in PwMS and
healthy subjects are provided in Table 2.
Healthy vs. fatigued MS patients
Our findings correspond to those reported in the previ-
ous section. Fatigued patients walked slower with
smaller steps and stride length, lower cadence, pro-
longed stance and double support phase, wider base of
support and a shorter single support phase compared to
healthy controls. In addition, fatigued patients demon-
strated elevated asymmetry between legs in terms of step
length, step time, single support and stance phase com-
pared to their healthy counterparts.
Correlation between gait measurements and
symptomatic fatigue
In the entire group, fatigue was significantly correlated
with 10 (out of 14) spatiotemporal parameters of gait.
However, correlation scores <0.40 were considered weak
correlations. Parameters not found to be significantly
correlated to the MFIS score were step width and 3 (out
of 4) asymmetry scores; step length, single support and
stance. In the non-fatigued group, correlations were ob-
served in 7 (out of 14) gait parameters. The strongest
scores were found for stance, single support and double
support phases, 0.356, -0.357, 0.359, respectively. In con-
trast, no significant correlations were found between the
MFIS score and gait parameters in the fatigued group.
Additionally, with respect to PwMS subgroups, no corre-
lations were found between the MFIS score to all 4 gaitTable 3 Spearman’s rho correlation scores; P-Value, between
Gait variable Total group (n = 124)
Velocity (km/h) −0.339; P < 0.001*
Cadence (steps/min) −0.322; P < 0.001*
Mean Step time (sec) 0.328; P < 0.001*
Mean Step length (sec) −0.274; P = 0.002*
Mean Stance (%GC) 0.372; P < 0.001*
Mean Single support (% GC) −0.372; P < 0.001*
Total Double support (% GC) 0.373; P < 0.001*
Mean Step width (cm) 0.171; P = 0.057
Mean Stride time (sec) 0.325; P < 0.001*
Mean Stride length (cm) −0.274; P = 0.002*
Step length asymmetry (cm) 0.094; P = 0.299
Step time asymmetry (msec) 0.205; P = 0.022*
Single support asymmetry (GC%) 0.052; P = 0.569
Stance asymmetry (GC%) 0.059; P = 0.515
*P < 0.05.asymmetry parameters. Correlation scores between gait
measurements and symptomatic fatigue are detailed in
Table 3.
Principal component analysis and linear regression
analysis
Bartlett’s test was significant (P < 0.001) indicating ap-
propriateness of the PCA for the present data set of
spatio-temporal gait variables. Three components had
eigenvalues >1.0 indicating eligibility for logistic regres-
sion analysis. Eigenvalues of the three components pre-
sented in a descending order were 7.86, 1.91, and 1.85,
respectively. Additionally, the cumulative % for the three
components was 56.3%, 13.7% and 13.2%, respectively, (a
total cumulative % of the selected components was
83.0%). Gait variables highly loaded with the first com-
ponent included, in particular, spatial parameters: mean
step length and mean stride length (referred to as the
spatial gait component). Variables highly loaded with the
second component included temporal gait parameters:
stride time, step time and cadence (referred to as the
temporal gait component). The third component was
highly loaded with gait asymmetrical variables: single
support asymmetry, stance phase asymmetry and step
time asymmetry (referred to as the asymmetry gait
component).
On basis of the PCA findings, a linear regression ana-
lysis was conducted. The three components derived
from the PCA were entered into the analysis as inde-
pendent variables; the MFIS score was defined as the
dependent variable. The results of the regression model
are shown in Table 4.
According to step one of the model, the temporal gait
component was found to explain 5.1% of the variancesymptomatic fatigue (MFIS) to gait parameters
Fatigue (n = 44) Non-fatigue (n = 80)
0.021; P = 0.890 −0.237; P = 0.034*
−0.143; P = 0.356 −0.285; P = 0.010*
0.143; P = 0.356 0.284; P = 0.011*
0.037; P = 0.810 −0.172; P = 0.128
−0.071; P = 0.648 0.356; P = 0.001*
0.086; P = 0.579 −0.357; P = 0.001*
−0.077; P = 0.621 0.359; P = 0.001*
0.002; P = 0.988 0.063; P = 0.579
0.137; P = 0.374 0.285; P = 0.011*
0.037; P = 0.809 −0.172; P = 0.128
−0.269; P = 0.077 0.167; P = 0.139
−0.155; P = 0.316 0.057; P = 0.618
−0.030; P = 0.846 −0.007; P = 0.947
−0.042; P = 0.789 0.025; P = 0.829
Table 4 Linear regression analysis for symptomatic fatigue according to spatio-temporal gait component
Model Variables Beta (Std.Error) t, P-value Odds ratio (95% C.I.)
1 Temporal gait component 0.538 (0.245) 4.805, P = 0.028* 1.713 (1.059, 2.771)
Constant −0.613(0.193) 10.113, P = 0.001* 0.542
2 Spatial gait component −0.482 (0.207) 5.414, P = 0.020* 0.617 (0.411, 0.927)
Temporal gait component 0.476 (0.219) 4.717, P = 0.030* 1.609 (1.048, 2.472)
Constant −0.737 (0.207) 12.625, P < 0.001* 1.3, 5.1
*P < 0.05.
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self-reported questionnaire, R2 = 0.051, χ2 (1) = 6.511,
P = 0.011. Step two of the model added the gait spatial
component, thus increasing the explaining variance to
9.3%; R2 = 0.093, χ2 (2) = 12.12, P = 0.002. The asym-
metry gait parameter did not explain the variance re-
lated to symptomatic fatigue.
Discussion
The primary objective of the present study was to exam-
ine the relationship between perceived fatigue and
spatio-temporal parameters of gait measured by an in-
strumented treadmill in PwMS. Given the high preva-
lence of these symptoms in the MS population in
addition to conflicting evidence as to the correlation be-
tween the two, supported this aim. Moreover, clarifica-
tion of this issue can be helpful to PwMS who suffer
from one or both of these symptoms and their corre-
sponding medical staff who often encounter these com-
plaints. Moreover, we examined gait with a relatively
innovative instrument. Compared to standard electronic
walkways, this device enables measurement over longer
distances, believed to be relevant for a relatively younger
aged experimental group.
Compared to the non-fatigued participants, patients in
the fatigued group walked significantly slower, with
shorter steps, a longer step time and prolonged double
support period. In total, the fatigued group performed
poorer in 9 (out of 14) gait parameters compared to the
non-fatigued participants. Moreover, according to the cor-
relation analysis, perceived fatigue was correlated with 10
(out of 14) gait parameters in the total sample group. The
strongest correlations were found for velocity (-0.339),
single (-0.372) and double support period (0.373).
Our findings concur with Sacco et al’s [20] and Motl
et al’s. [21] studies. Sacco showed negative correlations
between level of fatigue (physical sub category) and vel-
ocity (-0.54), cadence (-0.44) and stride length (-0.50).
Similarly, Motl et al. reported significant correlations be-
tween symptomatic fatigue and gait speed (-0.324), stride
length (-0.372) and double support period (0.420).
Interestingly, significant correlations between gait pa-
rameters to the level of self-reported fatigue were found
solely in the non-fatigue group. No correlations wereobserved in the MS fatigued patients. A possible explan-
ation could be a floor effect in terms of walking speed.
PwMS in the fatigue group walked at a mean speed of
1.7 (km/h) which is considered very slow, however, rela-
tively safe. Reducing speed at this rate is nearly impos-
sible since the walking belt of the treadmill barely
moves. There is a logical possibility that the majority of
people in the fatigue group preferred to ambulate within
a safe walking speed, regardless of the level of fatigue,
consequently, eliminating the likelihood of a significant
correlation between gait speed and perceived fatigue.
This trend did not occur in the non-fatigued partici-
pants’ group, who walked at a speed of 3.7 (km/h). In
this case, patients had a better possibility to adjust to the
speed of the belt according to their comfort level.
We are aware that one may argue that the different gait
performances observed between groups was simply a re-
flection of the general neurological condition represented
by the EDSS score. The mean EDSS score of the fatigued
patients were higher compared to the non-fatigued partic-
ipants; 3.7 (S.D = 1.8) and 2.5 (S.D = 1.6), P < 0.001, re-
spectively. Therefore, in order to address this assertion, a
regression model for the entire MS group was performed.
The MFIS was selected as the dependent variable while
spatio-temporal gait parameters served as explaining vari-
ables. Accordingly, we found that the temporal compo-
nent of gait (mainly indicating walking speed) explained
only 5.4% of the variance related to symptomatic fatigue;
hence, the majority of the variance should be explained by
other factors. Therefore, our results preclude the ability to
draw a firm conclusion as to the relationship between def-
inite gait parameters and perceived fatigue.
However, we present several possibilities that could be
considered a link between gait impairment and MS re-
lated fatigue. Morgante et al. conducted an MRI and
electrophysiological study on PwMS [36]. Their main
findings demonstrated that an increased burden of lesion
load in frontal areas correlates with the degree of fatigue
itself, expressed by the FSS score. This was paralleled by
a functional impairment of the motor areas involved in
movement planning and preparation. Interestingly, dis-
turbances in the frontal lobe were found related to a
cautious and slower gait pattern in the elderly [37]. Con-
sequently, we raise the possibility that lesions in the
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and a slower walking pattern.
To prove this hypothesis, we suggest that future studies
add a dual-task walking test to the common gait measure-
ments. A dual walking-thinking task requires additional
frontal lobe sources compared to normal walking, thus
providing an opportunity to precisely examine the rela-
tionship between fatigue, gait and frontal lobe activation
in the MS population.
Likewise, energy cost may link perceived fatigue and
walking disturbances in PwMS. However, this issue is still
controversial. Motl et al. [21] reported that energy cost
was inversely associated with gait speed and perceived fa-
tigue as measured by FSS in people with mild MS. In con-
trast, Kempen et al. [38] claimed that perceived fatigue
and energy cost during walking are not associated with
mild to moderate walking problems, indicating that these
are two separate constructs. Future studies are warranted
to clarify this debate.
Several clinical implications may be drawn from our
data. Practitioners should be aware that perceived fatigue
could contribute to a slower walking speed in PwMS.
Therefore, we propose that the management strategy to
reduce fatigue should include a walking intervention
program. Specifying that a treatment program designed
to increase walking speed may reduce the level of MS re-
lated fatigue.
On the other hand, in order to increase PwMS’s walk-
ing speed, a rehabilitation program based on a behav-
ioral component such as cognitive behavioral therapy
may be effective.
Interestingly, Bol et al. compared a cognitive-behavioral
approach with a biomechanical approach to explain fa-
tigue and physical disability in MS patients. Neither the
cognitive-behavioral nor the biomechanical model was ad-
equate. However, by incorporating the two models sug-
gests that an integrated approach could be beneficial in
the treatment of fatigue and gait [39]. Similarly, Coote et
al published a study protocol entitled “step it up” directed
at managing major symptoms of PwMS [40]. The protocol
describes a rehabilitation program based on 10 weeks of
exercise plus a social cognitive theory based on behavioral
change intervention. The authors plan to examine the effi-
cacy of this program on major MS-related symptoms, in-
cluding perceived fatigue.
Our study has several limitations. Firstly, categorization
between fatigued and non-fatigued PwMS was based
solely on the 38 point MFIS cut-off point. Although
Flachenecker et al’s [33] study reported that this score
is appropriate to differentiate between fatigue to non-
fatigued PwMS, a possibility exists that several partici-
pants were incorrectly classified, especially in cases
where the MFIS score was relatively close to the cut-off
point. Secondly, although this device is commonly usedin the general population, walking on a treadmill does
not duplicate walking in the natural environment. The
main differences consist of the afferent impulse and
fixed speed. These distinctions may have partly contrib-
uted to the differences demonstrated between the
groups. Nevertheless, walking speed in the present MS
study group was similar with those reported by differ-
ent trials measuring walking velocity on electronic mats
in the MS population.
We further note that we did not take into account
additional factors related to symptomatic fatigue such as
immunological abnormalities, depression and sleep dis-
orders, although the exact role of these variables in MS
related fatigue, is not fully understood. Furthermore, the
addition of physiological measurements during walking
such as heart rate and/or expired air measures of VO2
may have facilitated substantial information related to
level of fatigue.
Finally, the cross-sectional study design is a limitation
because it does not provide longitudinal data on the possi-
bility that elevated fatigue results in a worsening of com-
munity ambulation and fatigue over time in PwMS. This
design does not identify the direction of causality among
perceived fatigue and gait parameters; however, cross-
sectional data are generally a precursor for the design of
randomized controlled trials that isolate causality.
Conclusions
Presently, an important debate exists as to how MS-
related fatigue relates to the origin of the fatigue, since this
may determine the most appropriate treatment. Our study
demonstrated that definite gait parameters are associated
with perceived fatigue in persons with MS. Clinicians
should be aware that PwMS who suffer from perceived fa-
tigue, walk slower, with shorter steps, a longer step time
and prolonged double support period. Therefore, we
propose that the management strategy to reduce fatigue
should include a walking intervention program. Alterna-
tively, in order to increase PwMS’s walking speed, a re-
habilitation program based on a behavioral component
may be effective.
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